LUNG
Pulmonx Corp
Key Financials
Operating Income
$-53663000
↑ 7.0%
Net Income
$-54003000
↑ 4.2%
Revenue
$90.5M
↑ 8.0%
EPS (Diluted)
$-1.33
↑ 7.6%
Gross Profit
$67.1M
↑ 8.3%
Shareholders' Equity
$54.1M
↓ 36.9%
Total Liabilities
$75.2M
↓ 2.4%
Cash & Equivalents
$69.8M
↓ 1.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SD | 5/19/2026 | View on SEC |
| 10-Q | 5/4/2026 | View on SEC |
| 8-K | 4/29/2026 | View on SEC |
| ARS | 4/22/2026 | View on SEC |
| DEFA14A | 4/22/2026 | View on SEC |
| DEF 14A | 4/22/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| S-8 | 3/10/2026 | View on SEC |
| 10-K | 3/10/2026 | View on SEC |
| SCHEDULE 13G | 3/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LUNG |
| Company Name | Pulmonx Corp |
| CIK | 1127537 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-364-0400 |